Bank of Montreal Can Sells 125,492 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Bank of Montreal Can cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 38.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 201,028 shares of the medical device company’s stock after selling 125,492 shares during the period. Bank of Montreal Can owned about 0.10% of Cooper Companies worth $18,481,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of COO. Byrne Asset Management LLC acquired a new stake in Cooper Companies during the 4th quarter worth $33,000. OFI Invest Asset Management bought a new position in shares of Cooper Companies in the 4th quarter worth $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the fourth quarter worth $38,000. West Financial Advisors LLC bought a new stake in Cooper Companies in the fourth quarter valued at about $49,000. Finally, Atala Financial Inc acquired a new position in Cooper Companies in the fourth quarter valued at about $51,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Up 2.8 %

COO stock opened at $77.46 on Friday. The company has a market cap of $15.49 billion, a PE ratio of 39.72, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The business has a 50-day simple moving average of $84.64 and a 200 day simple moving average of $94.63.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on COO shares. Robert W. Baird reduced their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Stifel Nicolaus reduced their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. lowered their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Friday, March 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.